People with MS have persistently high levels of EBV antibodies, a study found, pointing to a way to distinguish MS from ...

What are the three types of HIV tests available to patients, how do they differ, and how can patients determine the best ...

Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.

Creative Biolabs today announced the upgrade of its next-generation drug discovery pipeline with integrated AI-driven ...

JCV is a DNA polyomavirus and the primary aetiological agent of PML. Most adults carry JCV in its latent form, but the virus ...

Almost all AAV cases were diagnosed in individuals with high pretest probability, including those with renal disease, peripheral neuropathies, or pulmonary infiltrates.

This is a rare opportunity for me personally, this is my only hope to extend my life by any real period at all." ...

The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other therapeutics represents one of the most consequential regulatory developments in ...

Astellas Pharma and CytomX Therapeutics first partnered up in March 2020. For $80 million upfront, the Japanese pharma gained access to the biotech’s Probody platform to generate masked antibody ...

Epstein-Barr virus antibodies could help differentiate MS from MOGAD and NMOSD. Discover how this biomarker may improve diagnosis. Read more.

Background Adalimumab is an effective first-line biologic therapy used to treat children and young people (CYP) with juvenile idiopathic arthritis (JIA) and non-infectious uveitis (NIU). However, the ...

The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...